Cargando…
NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2
SIMPLE SUMMARY: Bladder cancer is one of the most common malignant tumors of the urinary system, and its treatment is mainly surgical resection, supplemented by chemotherapy after surgery. Postoperative chemotherapy can significantly reduce the tumor recurrence rate and improve the prognosis of blad...
Autores principales: | Wang, Decai, Zhang, Pu, Liu, Zijian, Xing, Yifei, Xiao, Yajun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367313/ https://www.ncbi.nlm.nih.gov/pubmed/35954445 http://dx.doi.org/10.3390/cancers14153782 |
Ejemplares similares
-
NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer
por: Gui, Zhiming, et al.
Publicado: (2022) -
Transcriptional regulation of NDUFA4L2 by NFIB induces sorafenib resistance by decreasing reactive oxygen species in hepatocellular carcinoma
por: Zhou, Li, et al.
Publicado: (2022) -
Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma
por: Tang, Qin, et al.
Publicado: (2022) -
Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer
por: Zhang, Pu, et al.
Publicado: (2021) -
Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma
por: Eun, Jung Woo, et al.
Publicado: (2022)